Estimating Excess Mortality in Colon Cancer Patients
Author Information
Author(s): Aurélien Belot, Laurent Remontet, Guy Launoy, Valérie Jooste, Roch Giorgi
Primary Institution: Hospices Civils de Lyon
Hypothesis
Can competing risk models effectively estimate excess mortality and recurrent-event hazards in colon cancer patients?
Conclusion
The study found that the recurrence-free excess mortality hazard reached zero six months after treatment, indicating a significant reduction in excess mortality post-surgery.
Supporting Evidence
- The study analyzed 936 colon cancer patients who underwent curative surgery.
- It was found that the excess mortality hazard reached zero six months after treatment.
- The effects of sex, age, and cancer stage were assessed on local recurrence and distant metastasis.
Takeaway
This study looked at colon cancer patients and found that after surgery, the risk of dying from excess causes dropped to normal levels after six months.
Methodology
The study used a population-based dataset and competing risk models to analyze the effects of covariates on local recurrence, distant metastasis, and excess mortality.
Limitations
The analysis was limited to the first occurring event and did not account for subsequent recurrences or deaths after a recurrence.
Participant Demographics
The mean age at diagnosis was 71 years, with 49% women and 51% men, and various cancer stages represented.
Statistical Information
P-Value
p<0.05
Confidence Interval
[0.53; 0.94]
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website